Serial Number | 79209948 |
Word Mark | CIRQUILA |
Filing Date | Thursday, March 30, 2017 |
Status | 709 - CANCELLED - SECTION 71 |
Status Date | Friday, May 3, 2024 |
Registration Number | 5308969 |
Registration Date | Tuesday, October 17, 2017 |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 1, 2017 |
Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, May 3, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | NOVARTIS AG |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | CH |
Party Name | NOVARTIS AG |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | CH |
Party Name | NOVARTIS AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | CH |
Event Date | Event Description |
Wednesday, July 12, 2017 | NOTICE OF PUBLICATION |
Tuesday, August 1, 2017 | PUBLISHED FOR OPPOSITION |
Tuesday, October 17, 2017 | REGISTERED-PRINCIPAL REGISTER |
Thursday, November 16, 2017 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
Thursday, June 15, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, June 16, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, June 16, 2017 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
Saturday, June 17, 2017 | ASSIGNED TO EXAMINER |
Tuesday, June 20, 2017 | APPLICATION FILING RECEIPT MAILED |
Thursday, June 22, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, December 6, 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
Friday, May 3, 2024 | CANCELLED SECTION 71 |
Friday, December 22, 2017 | NOTIFICATION PROCESSED BY IB |
Wednesday, December 6, 2017 | FINAL DISPOSITION PROCESSED |